Cargando…

Targeted Radionuclide Therapy of Cancer and Infections

Detalles Bibliográficos
Autores principales:	van der Wal, Bart C. H., Dadachova, Ekaterina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219551/ https://www.ncbi.nlm.nih.gov/pubmed/37240433 http://dx.doi.org/10.3390/ijms24109081

Ejemplares similares

Targeting Melanin in Melanoma with Radionuclide Therapy
por: Allen, Kevin J. H., et al.
Publicado: (2022)

Usefulness of continuous probability distributions of rates for modelling radionuclide biokinetics in humans and animals
por: Shuryak, Igor, et al.
Publicado: (2019)

Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020)

Targeted Radionuclide Therapy
por: Ersahin, Devrim, et al.
Publicado: (2011)

Celebrating eighty years of radionuclide therapy and the work of Saul Hertz
por: Fahey, Frederic H., et al.
Publicado: (2021)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development
por: Tolmachev, Vladimir, et al.
Publicado: (2022)

Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
por: Damiana, Tyrillshall S. T., et al.
Publicado: (2021)

Targeted Radionuclide Therapy of Human Tumors
por: Gudkov, Sergey V., et al.
Publicado: (2015)

Introduction to Radiobiology of Targeted Radionuclide Therapy
por: Pouget, Jean-Pierre, et al.
Publicado: (2015)

Radionuclides for Targeted Therapy: Physical Properties
por: Stokke, Caroline, et al.
Publicado: (2022)

Current role of radionuclide imaging in differentiated thyroid cancer
por: Wong, K.T., et al.
Publicado: (2008)

Radionuclide carriers for targeting of cancer
por: Sofou, Stavroula
Publicado: (2008)

Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
por: Falzone, Nadia, et al.
Publicado: (2018)

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
por: D’Huyvetter, Matthias, et al.
Publicado: (2014)

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment
por: Kerr, Caroline P., et al.
Publicado: (2022)

Clinical Advances and Perspectives in Targeted Radionuclide Therapy
por: Lepareur, Nicolas, et al.
Publicado: (2023)

Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013)

Future Vistas in Alpha Therapy of Infectious Diseases
por: Dadachova, Ekaterina
Publicado: (2019)

Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
por: Kleinendorst, Simone C., et al.
Publicado: (2022)

Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
por: Idrissou, Malick Bio, et al.
Publicado: (2021)

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
por: Huynh, Truc T., et al.
Publicado: (2022)

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade
por: Al-Toubah, Taymeyah, et al.
Publicado: (2023)

Targeted Radionuclide Therapy: Practical Applications and Future Prospects
por: Zukotynski, Katherine, et al.
Publicado: (2016)

Targeted Palliative Radionuclide Therapy for Metastatic Bone Pain
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2020)

EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides
por: Handkiewicz-Junak, Daria, et al.
Publicado: (2018)

Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review
por: Li, Tiantian, et al.
Publicado: (2017)

Covalent Proteins as Targeted Radionuclide Therapies Enhance Antitumor Effects
por: Klauser, Paul C., et al.
Publicado: (2023)

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

[(123)I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
por: Chan, Chung Ying, et al.
Publicado: (2023)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
por: Ruigrok, Eline A.M., et al.
Publicado: (2019)

Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies
por: Privé, Bastiaan M., et al.
Publicado: (2023)

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy
por: Obata, Honoka, et al.
Publicado: (2023)

Evaluating the Targeting of a Staphylococcus-aureus-Infected Implant with a Radiolabeled Antibody In Vivo
por: van Dijk, Bruce, et al.
Publicado: (2023)

Targeted Radionuclide Therapy of Prostate Cancer—From Basic Research to Clinical Perspectives
por: Czerwińska, Malwina, et al.
Publicado: (2020)

Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018)

Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections
por: Dadachova, Ekaterina, et al.
Publicado: (2011)

Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
por: Koustoulidou, Sofia, et al.
Publicado: (2021)

Novel radionuclide therapy combinations in prostate cancer
por: Inderjeeth, Andrisha–Jade, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8qcoge4868idbpo6gl7fq6vht2